Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biomarkers ; 25(5): 384-390, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32475174

RESUMO

Introduction: The aim of this study was to evaluate the methylation status of TNF-α and SOCS3 promoters in patients with BD and compare them with a healthy group.Method: This was a case-control study, in which 47 subjects with BD and 61 individuals as the control participated. Blood samples were collected from all the participants. Then, PBMCs were isolated using the Ficoll method and methylation of considered sites was investigated using the qMS-PCR technique after DNA extraction by the rapid genomic DNA extraction method and its analysis with Nano-drop.Results: The methylation and expression of TNF-α showed that the methylation level significantly declined in the patient in comparison with the healthy (p < 0.05). Moreover, the results on the mean expression showed that it significantly increased in the patient group, as compared with the healthy group (p < 0.05). In addition, the expression of the SOCS3 gene was not significantly different between the patients and healthy subjects while the level of SOCS3 methylation was significantly higher in the patient group than that in the healthy group (p < 0.05).Discussion: The present study revealed that the gene expression of TNF-alpha increased in BD patients, suggesting that TNF-alpha likely has a role in the pathogenesis of BD.


Assuntos
Síndrome de Behçet/genética , Predisposição Genética para Doença , Proteína 3 Supressora da Sinalização de Citocinas/genética , Fator de Necrose Tumoral alfa/genética , Adulto , Síndrome de Behçet/patologia , Biomarcadores/metabolismo , Estudos de Casos e Controles , Metilação de DNA/genética , Feminino , Regulação da Expressão Gênica/genética , Humanos , Masculino , Pessoa de Meia-Idade , Regiões Promotoras Genéticas/genética
2.
Drug Res (Stuttg) ; 67(4): 198-203, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28208189

RESUMO

Nanotechnology is one of the most promising fields for producing new applications in nanotechnology, biotechnology, and medicine. However, only a few products have been used for nanotechnology, biotechnology, and medical purposes. Nanoparticles have been among the most usually applied nanomaterial in our health care system for hundreds of years. The most prominent nano product is nano silver which generally present at 1-100 nm in size in at least one dimension. Silver nanoparticles reveal remarkably unusual chemical, physical and biological properties and have been used for many different applications which detailed in this review. This review is focusing on the different form of silver nanoparticles and its nanotechnological, biotechnological and medical applications.


Assuntos
Nanopartículas Metálicas/química , Nanoestruturas/química , Nanotecnologia/métodos , Prata/química , Nanopartículas Metálicas/administração & dosagem , Nanopartículas Metálicas/uso terapêutico , Nanoestruturas/administração & dosagem , Nanoestruturas/uso terapêutico , Prata/administração & dosagem , Prata/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA